Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Ranelic Acid

Known as: 5-(Bis(carboxymethyl)amino)-2-carboxy-4-cyano-3-thiopheneacetic Acid 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
This is a review of the pharmacology of strontium ranelate (Protelos®, Protos®, Protaxos®, Bivalos®, Osseor®), and its efficacy… Expand
  • figure 1
  • table I
  • figure 2
  • table II
  • table III
Is this relevant?
2010
2010
Introduction Strontium ranelate is an agent used for the treatment of osteoporosis. It consists of two atoms of stable strontium… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2010
Review
2010
This is a review of the pharmacology of strontium ranelate (Protelos®, Protos®, Protaxos®, Bivalos®, Osseor®), and its efficacy… Expand
Is this relevant?
2008
2008
Drug therapy of osteoporosis is fundamentally changing. Treatments that are available today can halve the risk of a vertebral… Expand
Is this relevant?
2008
2008
In the title compound, C16H18N2O8S, derived from ranelic acid, there is a highly substituted thiophene ring. The crystal… Expand
  • table 1
  • figure 1
  • figure 2
Is this relevant?
2007
2007
The title compound, 5-[bis­(ethoxy­carbonyl­meth­yl)amino]-4-cyano-2-ethoxy­carbonyl-3-thio­phene­propionate, C20H26N2O8S, is a… Expand
Is this relevant?
2004
2004
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… Expand
Is this relevant?
2003
2003
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… Expand
Is this relevant?